Fundació Privada Institut d'Investigació Oncològica de Vall Hebron
发明人:
Soucek, Laura,Beaulieu, Marie-Eve
申请号：
HRP20191330
公开号：
HRP20191330T1
申请日:
2019.07.23
申请国别(地区):
HR
年份:
2019
代理人:
摘要：
The invention relates to a Myc dominant negative mutant, called Omomyc, for use in medicine and for use in the prevention and/or treatment of cancer. The invention also refers to a fusion protein comprising Omomyc and pharmaceutical composition thereof and their use in medicine and, in particular, for treatment of cancer.
